Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStandard Chartered Regulatory News (STAN)

Share Price Information for Standard Chartered (STAN)

Share Price is delayed by 15 minutes
Get Live Data
1,811.00    -122.00 (-6.31%)
Bid:
1,821.50
Ask:
1,822.50
Spread: 1.00 (0.055%)
Market Cap: £39.52b
STAN Live PriceLast checked at - London Stock Exchange

Intraday Standard Chartered Share Chart

Share Buy-Back

31 Jul 2023 10:15

RNS Number : 7355H
Standard Chartered PLC
31 July 2023
 

STANDARD CHARTERED PLC

31 July 2023

SHARE BUY-BACK

Standard Chartered PLC (the Group) announces that, as noted in its announcement on 28 July 2023, it will commence buying-back ordinary shares of US$0.50 each (the Ordinary Shares) and for a value of up to US$1 billion (the Buy-back). The purpose of the Buy-back is to reduce the Group's outstanding Ordinary Shares. The Buy-back will run concurrently with the Group's existing share buy-back programme previously announced on 17 February 2023 (the Existing Buy-back). Accordingly, the Group has now announced buy-back programmes for a value of up to US$2 billion to take place over the course of 2023.

The Group has entered into a non-discretionary agreement with Goldman Sachs International (GS) to enable the purchase of Ordinary Shares by GS, acting as principal, during the period running from 1 August 2023 to no later than 22 December 2023 (subject to no regulatory objections or concerns arising), for a value of up to, but no greater than, US$1 billion and the on-sale of such Ordinary Shares by GS to the Group. GS will make its trading decisions in relation to the Ordinary Shares independently of the Group.

The maximum number of Ordinary Shares that can be purchased under the Buy-back is 245,000,000 Ordinary Shares (the Share Maximum) (based on authority granted at the Group's 2023 annual general meeting) after taking account of Ordinary Shares already purchased under the Existing Buy-back. The Buy-back will end no later than 22 December 2023 or when the aggregate number of Shares purchased under the Buy-Back and the Existing Buy-back after this announcement would exceed the Share Maximum. The Existing Buy-back will end as detailed in the 17 February 2023 announcement or when the aggregate number of Shares purchased under the Existing Buy-back and the Buy-back after this announcement would exceed the Share Maximum.

Any purchases of Ordinary Shares will be carried out on the London Stock Exchange and Cboe Europe Limited (through the BXE and CXE order books), and any other UK recognised investment exchange which may be agreed. The Buy-back will be effected within certain pre-set parameters and in accordance with (and subject to limits prescribed by) the Group's general authority to repurchase Ordinary Shares granted by its shareholders at its most recent annual general meeting, Chapter 12 of the Financial Conduct Authority's Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), the Rules Governing the Listing of Securities on the Stock Exchange of Hong Kong Limited and the Hong Kong Codes on Takeovers and Mergers and Share Buy-Backs. For the avoidance of doubt, no purchases of Ordinary Shares will be carried out on the Stock Exchange of Hong Kong Limited. Ordinary Shares purchased under the Buy-back will be cancelled.

For further information, please contact:

Gregg J Powell, Group Head, Investor Relations: +44 (0) 20 7885 5172

Shaun Gamble, Director, Group Media Relations: +44 (0) 20 7885 5934

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSDASUFEDSESW
Date   Source Headline
9th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 202610:32 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSIssuance of Additional Tier 1 Securities
28th May 20264:40 pmRNSAdmission to Trading & Publication of Final Terms
28th May 20264:04 pmRNSAdmission to Trading & Publication of Final Terms
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSStandard Chartered Investor Event 2026 Day 2
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20263:00 pmRNSDirector/PDMR Shareholding
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20262:50 pmRNSPublication of Supplementary Prospectus
19th May 20267:00 amRNSStandard Chartered targets ~ 18% RoTE in 2030
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:10 amRNSTransaction in Own Shares
18th May 20267:00 amRNSDirectorate and Group Management Team Changes
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20262:56 pmRNSResult of AGM
7th May 202611:04 amRNSAGM Statement
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20265:58 pmRNSTransaction in Own Shares
1st May 202611:46 amRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 202612:40 pmRNSPublication of a Supplementary Prospectus
30th Apr 202610:13 amRNSQ1 2026 Pillar 3 Disclosures
30th Apr 20267:05 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNS1st Quarter Results
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20262:45 pmRNSPublication of a Prospectus
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.